384 related articles for article (PubMed ID: 25936422)
21. Downregulation of MACC1 expression enhances cisplatin sensitivity in SKOV-3/DDP cells.
Chen ZM; Shi HR; Li X; Deng YX; Zhang RT
Genet Mol Res; 2015 Dec; 14(4):17134-44. PubMed ID: 26681060
[TBL] [Abstract][Full Text] [Related]
22. Multikinase inhibitor motesanib enhances the antitumor effect of cisplatin in cisplatin‑resistant human bladder cancer cells via apoptosis and the PI3K/Akt pathway.
Ho JN; Byun SS; Lee SE; Youn JI; Lee S
Oncol Rep; 2019 Apr; 41(4):2482-2490. PubMed ID: 30816494
[TBL] [Abstract][Full Text] [Related]
23. [The effect of Bcl-2 gene silencing on the sensitivity of cell line A549 to chemotherapeutic drugs].
Wang JQ; Du ZW; Gao XF; Wu M; Zhang YC; Pan Y; Wang Q; Zhang GZ
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):191-7. PubMed ID: 23856142
[TBL] [Abstract][Full Text] [Related]
24. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
25. Effects of shRNA Targeting Maspin on the Invasion of Extravillous Trophoblast Cell.
Shi X; Liu Q; Liu H; Deng D; Qiao F; Wu Y
Am J Perinatol; 2017 Aug; 34(10):966-973. PubMed ID: 28376551
[No Abstract] [Full Text] [Related]
26. Silencing GOLPH3 gene expression reverses resistance to cisplatin in HT29 colon cancer cells via multiple signaling pathways.
Zhou ZP; Wang LP; Hong ZS; Qiu CZ; Wang MZ; Chen ZX; Tang LF; Yu WS; Wang CX
Int J Oncol; 2018 Sep; 53(3):1183-1192. PubMed ID: 30015866
[TBL] [Abstract][Full Text] [Related]
27. 5-azacytidine reverses drug resistance in bladder cancer cells.
Ramachandran K; Gordian E; Singal R
Anticancer Res; 2011 Nov; 31(11):3757-66. PubMed ID: 22110197
[TBL] [Abstract][Full Text] [Related]
28. The tumor suppressor maspin mediates E2F1-induced sensitivity of cancer cells to chemotherapy.
Ben Shachar B; Feldstein O; Hacohen D; Ginsberg D
Mol Cancer Res; 2010 Mar; 8(3):363-72. PubMed ID: 20197383
[TBL] [Abstract][Full Text] [Related]
29. TRIM29 Overexpression Promotes Proliferation and Survival of Bladder Cancer Cells through NF-κB Signaling.
Tan ST; Liu SY; Wu B
Cancer Res Treat; 2016 Oct; 48(4):1302-1312. PubMed ID: 26987391
[TBL] [Abstract][Full Text] [Related]
30. Upregulated expression of BCL2, MCM7, and CCNE1 indicate cisplatin-resistance in the set of two human bladder cancer cell lines: T24 cisplatin sensitive and T24R2 cisplatin resistant bladder cancer cell lines.
Kim SH; Ho JN; Jin H; Lee SC; Lee SE; Hong SK; Lee JW; Lee ES; Byun SS
Investig Clin Urol; 2016 Jan; 57(1):63-72. PubMed ID: 26966728
[TBL] [Abstract][Full Text] [Related]
31. Synergistic antitumor effect of ginsenoside Rg3 and cisplatin in cisplatin‑resistant bladder tumor cell line.
Lee YJ; Lee S; Ho JN; Byun SS; Hong SK; Lee SE; Lee E
Oncol Rep; 2014 Nov; 32(5):1803-8. PubMed ID: 25175462
[TBL] [Abstract][Full Text] [Related]
32. RNA interference‑mediated inhibition of survivin and VEGF in pancreatic cancer cells in vitro.
Song J; Cao L; Li Y
Mol Med Rep; 2013 May; 7(5):1651-5. PubMed ID: 23467576
[TBL] [Abstract][Full Text] [Related]
33. Higher expression of SIRT1 induced resistance of esophageal squamous cell carcinoma cells to cisplatin.
Cao B; Shi Q; Wang W
J Thorac Dis; 2015 Apr; 7(4):711-9. PubMed ID: 25973238
[TBL] [Abstract][Full Text] [Related]
34. Notch-1 regulates proliferation and differentiation of human bladder cancer cell lines by inhibiting expression of Krüppel-like factor 4.
Ai X; Jia Z; Liu S; Wang J; Zhang X
Oncol Rep; 2014 Oct; 32(4):1459-64. PubMed ID: 25109409
[TBL] [Abstract][Full Text] [Related]
35. [Effects of PTEN gene transfection on proliferation and invasion of human bladder cancer cell line BIU87].
Zhang JH; Yang WM; Zhou SW; Chen Z
Ai Zheng; 2006 May; 25(5):555-9. PubMed ID: 16687073
[TBL] [Abstract][Full Text] [Related]
36. Expression of livin in gastric cancer and induction of apoptosis in SGC-7901 cells by shRNA-mediated silencing of livin gene.
Wang TS; Ding QQ; Guo RH; Shen H; Sun J; Lu KH; You SH; Ge HM; Shu YQ; Liu P
Biomed Pharmacother; 2010 May; 64(5):333-8. PubMed ID: 19914791
[TBL] [Abstract][Full Text] [Related]
37. Effect of siRNA targeting EZH2 on cell viability and apoptosis of bladder cancer T24 cells.
Wang HF; Yang H; Hu LB; Lei YH; Qin Y; Li J; Bi CW; Wang JS; Huo Q
Genet Mol Res; 2014 Nov; 13(4):9939-50. PubMed ID: 25501205
[TBL] [Abstract][Full Text] [Related]
38. Study of 5-Aza-CdR on transcription regulation of RASSF1A gene in the BIU87 cell line.
Liu X; Dai X; Wu B
Urol Int; 2009; 82(1):108-12. PubMed ID: 19172108
[TBL] [Abstract][Full Text] [Related]
39. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
[TBL] [Abstract][Full Text] [Related]
40. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
